1
|
Qu Y, Chen M, Wang Y, Qu L, Wang R, Liu H, Wang L, Nie Z. Rapid screening of infertility-associated gynecological conditions via ambient glow discharge mass spectrometry utilizing urine metabolic fingerprints. Talanta 2024; 274:125969. [PMID: 38608629 DOI: 10.1016/j.talanta.2024.125969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Revised: 02/29/2024] [Accepted: 03/20/2024] [Indexed: 04/14/2024]
Abstract
Infertility presents a widespread challenge for many families worldwide, often arising from various gynecological diseases (GDs) that hinder successful pregnancies. Current diagnostic methods for GDs have disadvantages such as low efficiency, high cost, misdiagnose, invasive injury and etc. This paper introduces a rapid, non-invasive, efficient, and straightforward analytical method that utilizes desorption, separation, and ionization mass spectrometry (DSI-MS) platform in conjunction with machine learning (ML) to detect urine metabolite fingerprints in patients with different GDs. We analyzed 257 samples from patients diagnosed with polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), diminished ovarian reserve (DOR), endometriosis (EMS), recurrent pregnancy loss (RPL), recurrent implantation failure (RIF), and 87 samples from healthy control (HC) individuals. We identified metabolite differences and dysregulated pathways through dimensionality reduction methods, with the result of the discovery of 7 potential biomarkers for GDs diagnosis. The ML method effectively distinguished subtle differences in urine metabolite fingerprints. We anticipate that this innovative approach will offer a patient-friendly, rapid screening, and differentiation method for infertility-related GDs patients.
Collapse
Affiliation(s)
- Yijiao Qu
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100190, China
| | - Ming Chen
- Centre of Reproductive Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, China; Department of Gynecology and Obstetrics, Guangxi University of Chinese Medicine, Nanning, 530200, China
| | - Yiran Wang
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100190, China
| | - Liangliang Qu
- School of Life Sciences, Nanchang University, Nanchang, 330031, China
| | - Ruiyue Wang
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100190, China
| | - Huihui Liu
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100190, China
| | - Liping Wang
- Centre of Reproductive Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, China.
| | - Zongxiu Nie
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100190, China.
| |
Collapse
|
2
|
Lee S, Dang H, Moon JI, Kim K, Joung Y, Park S, Yu Q, Chen J, Lu M, Chen L, Joo SW, Choo J. SERS-based microdevices for use as in vitro diagnostic biosensors. Chem Soc Rev 2024. [PMID: 38597213 DOI: 10.1039/d3cs01055d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/11/2024]
Abstract
Advances in surface-enhanced Raman scattering (SERS) detection have helped to overcome the limitations of traditional in vitro diagnostic methods, such as fluorescence and chemiluminescence, owing to its high sensitivity and multiplex detection capability. However, for the implementation of SERS detection technology in disease diagnosis, a SERS-based assay platform capable of analyzing clinical samples is essential. Moreover, infectious diseases like COVID-19 require the development of point-of-care (POC) diagnostic technologies that can rapidly and accurately determine infection status. As an effective assay platform, SERS-based bioassays utilize SERS nanotags labeled with protein or DNA receptors on Au or Ag nanoparticles, serving as highly sensitive optical probes. Additionally, a microdevice is necessary as an interface between the target biomolecules and SERS nanotags. This review aims to introduce various microdevices developed for SERS detection, available for POC diagnostics, including LFA strips, microfluidic chips, and microarray chips. Furthermore, the article presents research findings reported in the last 20 years for the SERS-based bioassay of various diseases, such as cancer, cardiovascular diseases, and infectious diseases. Finally, the prospects of SERS bioassays are discussed concerning the integration of SERS-based microdevices and portable Raman readers into POC systems, along with the utilization of artificial intelligence technology.
Collapse
Affiliation(s)
- Sungwoon Lee
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Hajun Dang
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Joung-Il Moon
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Kihyun Kim
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Younju Joung
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Sohyun Park
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Qian Yu
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Jiadong Chen
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Mengdan Lu
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| | - Lingxin Chen
- School of Pharmacy, Binzhou Medical University, Yantai, 264003, China
- CAS Key Laboratory of Coastal Environmental Processes and Ecological Remediation, Yantai Institute of Coastal Zone Research, Yantai 264003, China.
| | - Sang-Woo Joo
- Department of Information Communication, Materials, and Chemistry Convergence Technology, Soongsil University, Seoul 06978, South Korea.
| | - Jaebum Choo
- Department of Chemistry, Chung-Ang University, Seoul 06974, South Korea.
| |
Collapse
|
3
|
Buhas BA, Toma V, Beauval JB, Andras I, Couți R, Muntean LAM, Coman RT, Maghiar TA, Știufiuc RI, Lucaciu CM, Crisan N. Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques. Int J Mol Sci 2024; 25:3891. [PMID: 38612705 PMCID: PMC11011951 DOI: 10.3390/ijms25073891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2024] [Revised: 03/29/2024] [Accepted: 03/29/2024] [Indexed: 04/14/2024] Open
Abstract
The advent of Surface-Enhanced Raman Scattering (SERS) has enabled the exploration and detection of small molecules, particularly in biological fluids such as serum, blood plasma, urine, saliva, and tears. SERS has been proposed as a simple diagnostic technique for various diseases, including cancer. Renal cell carcinoma (RCC) ranks as the sixth most commonly diagnosed cancer in men and is often asymptomatic, with detection occurring incidentally. The onset of symptoms typically aligns with advanced disease, aggressive histology, and unfavorable prognosis, and therefore new methods for an early diagnosis are needed. In this study, we investigated the utility of label-free SERS in urine, coupled with two multivariate analysis approaches: Principal Component Analysis combined with Linear Discriminant Analysis (PCA-LDA) and Support Vector Machine (SVM), to discriminate between 50 RCC patients and 44 healthy donors. Employing LDA-PCA, we achieved a discrimination accuracy of 100% using 13 principal components, and an 88% accuracy in discriminating between different RCC stages. The SVM approach yielded a training accuracy of 100%, a validation accuracy of 99% for discriminating between RCC and controls, and an 80% accuracy for discriminating between stages. The comparative analysis of raw and normalized SERS spectral data shows that while raw data disclose relative concentration variations in urine metabolites between the two classes, the normalization of spectral data significantly improves the accuracy of discrimination. Moreover, the selection of principal components with markedly distinct scores between the two classes serves to alleviate overfitting risks and reduces the number of components employed for discrimination. We obtained the accuracy of the discrimination between the RCC patients cases and healthy donors of 90% for three PCs and a linear discrimination function, and a 88% accuracy of discrimination between stages using six PCs, mitigating practically the risk of overfitting and increasing the robustness of our analysis. Our findings underscore the potential of label-free SERS of urine in conjunction with chemometrics for non-invasive and early RCC detection.
Collapse
Affiliation(s)
- Bogdan Adrian Buhas
- Department of Urology, La Croix du Sud Hospital, 52 Chemin de Ribaute St., 31130 Quint Fonsegrives, France; (B.A.B.); (J.-B.B.)
- Department of Urology, Clinical Municipal Hospital, 11 Tabacarilor St., 400139 Cluj-Napoca, Romania; (I.A.); (N.C.)
- Faculty of Medicine and Pharmacy, University of Oradea, 1 Universitatii St., 410087 Oradea, Romania; (R.C.); (T.A.M.)
| | - Valentin Toma
- Department of Nanobiophysics, MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 4-6 Pasteur St., 400337 Cluj-Napoca, Romania;
| | - Jean-Baptiste Beauval
- Department of Urology, La Croix du Sud Hospital, 52 Chemin de Ribaute St., 31130 Quint Fonsegrives, France; (B.A.B.); (J.-B.B.)
| | - Iulia Andras
- Department of Urology, Clinical Municipal Hospital, 11 Tabacarilor St., 400139 Cluj-Napoca, Romania; (I.A.); (N.C.)
- Faculty of Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 8 Victor Babes St., 400347 Cluj-Napoca, Romania
| | - Răzvan Couți
- Faculty of Medicine and Pharmacy, University of Oradea, 1 Universitatii St., 410087 Oradea, Romania; (R.C.); (T.A.M.)
| | - Lucia Ana-Maria Muntean
- Department of Medical Education, “Iuliu Hatieganu” University of Medicine and Pharmacy, 8 Victor Babes St., 400347 Cluj-Napoca, Romania;
| | - Radu-Tudor Coman
- Faculty of Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 8 Victor Babes St., 400347 Cluj-Napoca, Romania
| | - Teodor Andrei Maghiar
- Faculty of Medicine and Pharmacy, University of Oradea, 1 Universitatii St., 410087 Oradea, Romania; (R.C.); (T.A.M.)
| | - Rareș-Ionuț Știufiuc
- Department of Nanobiophysics, MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 4-6 Pasteur St., 400337 Cluj-Napoca, Romania;
- Department of Pharmaceutical Physics–Biophysics, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, 6 Pasteur St., 400349 Cluj-Napoca, Romania
- Nanotechnology Laboratory, TRANSCEND Research Center, Regional Institute of Oncology, 700483 Iași, Romania
| | - Constantin Mihai Lucaciu
- Department of Pharmaceutical Physics–Biophysics, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, 6 Pasteur St., 400349 Cluj-Napoca, Romania
| | - Nicolae Crisan
- Department of Urology, Clinical Municipal Hospital, 11 Tabacarilor St., 400139 Cluj-Napoca, Romania; (I.A.); (N.C.)
- Faculty of Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 8 Victor Babes St., 400347 Cluj-Napoca, Romania
| |
Collapse
|
4
|
Yu HJ, Jang E, Woo A, Han IW, Jeon HG, Linh VTN, Park SG, Jung HS, Lee MY. Cancer screening through surface-enhanced Raman spectroscopy fingerprinting analysis of urinary metabolites using surface-carbonized silver nanowires on a filter membrane. Anal Chim Acta 2024; 1292:342233. [PMID: 38309850 DOI: 10.1016/j.aca.2024.342233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Revised: 11/05/2023] [Accepted: 01/09/2024] [Indexed: 02/05/2024]
Abstract
BACKGROUND Label-free surface-enhanced Raman spectroscopy (SERS)-based metabolic profiling has great potential for early cancer diagnosis, but further advancements in analytical methods and clinical evidence studies are required for clinical applications. To improve the cancer diagnostic accuracy of label-free SERS spectral analysis of complex biological fluids, it is necessary to obtain specifically enhanced SERS signals of cancer-related metabolites present at low concentrations. RESULTS This study presents a novel 3D SERS sensor, comprising a surface-carbonized silver nanowire (AgNW)-stacked filter membrane, alongside an optimized urine/methanol/chloroform extraction technique, which specifically changes the molecular adsorption and orientation of aromatic metabolites onto SERS substrates. By analyzing the pretreated urine samples on the surface-carbonized AgNW 3D SERS sensor, distinct and highly enhanced SERS peaks derived from semi-polar aromatic metabolites were observed for pancreatic cancer and prostate cancer samples compared with normal controls. Urine metabolite analysis using SERS fingerprinting successfully differentiated pancreatic cancer and prostate cancer groups from normal control group: normal control (n = 56), pancreatic cancer (n = 40), and prostate cancer (n = 39). SIGNIFICANCE AND NOVELTY We confirmed the clinical feasibility of performing fingerprint analysis of urinary metabolites based on the surface-carbonized AgNW 3D SERS sensor and methanol/chloroform extraction for noninvasive cancer screening. This technology holds potential for large-scale screening owing to its high accuracy, and cost effective, simple and rapid detection method.
Collapse
Affiliation(s)
- Ho-Jae Yu
- Medical Device Research Center, Samsung Medical Center, Seoul, 06351, Republic of Korea
| | - Eunji Jang
- Nano-Bio Convergence Department, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, Republic of Korea
| | - Ayoung Woo
- Medical Device Research Center, Samsung Medical Center, Seoul, 06351, Republic of Korea
| | - In Woong Han
- Division of Hepato Biliary Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea
| | - Hwang Gyun Jeon
- Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea
| | - Vo Thi Nhat Linh
- Nano-Bio Convergence Department, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, Republic of Korea
| | - Sung-Gyu Park
- Nano-Bio Convergence Department, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, Republic of Korea
| | - Ho Sang Jung
- Nano-Bio Convergence Department, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, Republic of Korea.
| | - Min-Young Lee
- Nano-Bio Convergence Department, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, Republic of Korea.
| |
Collapse
|
5
|
Linh VTN, Kim H, Lee MY, Mun J, Kim Y, Jeong BH, Park SG, Kim DH, Rho J, Jung HS. 3D plasmonic hexaplex paper sensor for label-free human saliva sensing and machine learning-assisted early-stage lung cancer screening. Biosens Bioelectron 2024; 244:115779. [PMID: 37922808 DOI: 10.1016/j.bios.2023.115779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 10/16/2023] [Accepted: 10/21/2023] [Indexed: 11/07/2023]
Abstract
A label-free detection method for noninvasive biofluids enables rapid on-site disease screening and early-stage cancer diagnosis by analyzing metabolic alterations. Herein, we develop three-dimensional plasmonic hexaplex nanostructures coated on a paper substrate (3D-PHP). This flexible and highly absorptive 3D-PHP sensor is integrated with commercial saliva collection tube to create an efficient on-site sensing platform for lung cancer screening via surface-enhanced Raman scattering (SERS) measurement of human saliva. The multispike hexaplex-shaped gold nanostructure enhances contact with saliva viscosity, enabling effective sampling and SERS enhancement. Through testing patient salivary samples, the 3D-PHP sensor demonstrates successful lung cancer detection and diagnosis. A logistic regression-based machine learning model successfully classifies benign and malignant patients, exhibiting high clinical sensitivity and specificity. Additionally, important Raman peak positions related to different lung cancer stages are investigated, suggesting insights for early-stage cancer diagnosis. Integrating 3D-PHP senor with the conventional saliva collection tube platform is expected to offer promising practicality for rapid on-site disease screening and diagnosis, and significant advancements in cancer detection and patient care.
Collapse
Affiliation(s)
- Vo Thi Nhat Linh
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, 51508, South Korea
| | - Hongyoon Kim
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - Min-Young Lee
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, 51508, South Korea
| | - Jungho Mun
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - Yeseul Kim
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - Byeong-Ho Jeong
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea
| | - Sung-Gyu Park
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, 51508, South Korea
| | - Dong-Ho Kim
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, 51508, South Korea; Advanced Materials Engineering Division, University of Science and Technology (UST), Daejeon, 34113, South Korea.
| | - Junsuk Rho
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea; Department of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea; POSCO-POSTECH-RIST Convergence Research Center for Flat Optics and Metaphotonics, Pohang, 37673, South Korea.
| | - Ho Sang Jung
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, 51508, South Korea; Advanced Materials Engineering Division, University of Science and Technology (UST), Daejeon, 34113, South Korea; School of Convergence Science and Technology, Medical Science and Engineering, POSTECH, Pohang, 37673, South Korea.
| |
Collapse
|
6
|
Farnesi E, Rinaldi S, Liu C, Ballmaier J, Guntinas-Lichius O, Schmitt M, Cialla-May D, Popp J. Label-Free SERS and MD Analysis of Biomarkers for Rapid Point-of-Care Sensors Detecting Head and Neck Cancer and Infections. Sensors (Basel) 2023; 23:8915. [PMID: 37960614 PMCID: PMC10648186 DOI: 10.3390/s23218915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 10/05/2023] [Accepted: 10/17/2023] [Indexed: 11/15/2023]
Abstract
For the progress of point-of-care medicine, where individual health status can be easily and quickly monitored using a handheld sensor, saliva serves as one of the best-suited body fluids thanks to its availability and abundance of physiological indicators. Salivary biomarkers, combined with rapid and highly sensitive detection tools, may pave the way to new real-time health monitoring and personalized preventative therapy branches using saliva as a target matrix. Saliva is increasing in importance in liquid biopsy, a non-invasive approach that helps physicians diagnose and characterize specific diseases in patients. Here, we propose a proof-of-concept study combining the unique specificity in biomolecular recognition provided by surface-enhanced Raman spectroscopy (SERS) in combination with molecular dynamics (MD) simulations, which give leave to explore the biomolecular absorption mechanism on nanoparticle surfaces, in order to verify the traceability of two validated salivary indicators, i.e., interleukin-8 (IL-8) and lysozyme (LYZ), implicated in oropharyngeal squamous cell carcinoma (OSCC) and oral infection. This strategy simultaneously assures the detection and interpretation of protein biomarkers in saliva, ultimately opening a new route for the evolution of fast and accurate point-of-care SERS-based sensors of interest in precision medicine diagnostics.
Collapse
Affiliation(s)
- Edoardo Farnesi
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany; (E.F.); (C.L.); (M.S.); (J.P.)
- Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany
| | - Silvia Rinaldi
- Institute for the Chemistry of Organo Metallic Compounds, National Research Council of Italy (CNR), Via Madonna del Piano 10, Sesto Fiorentino, 50019 Florence, Italy;
| | - Chen Liu
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany; (E.F.); (C.L.); (M.S.); (J.P.)
- Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany
| | - Jonas Ballmaier
- Department of Otorhinolaryngology-Head and Neck Surgery, Jena University Hospital, 07747 Jena, Germany; (J.B.); (O.G.-L.)
| | - Orlando Guntinas-Lichius
- Department of Otorhinolaryngology-Head and Neck Surgery, Jena University Hospital, 07747 Jena, Germany; (J.B.); (O.G.-L.)
| | - Michael Schmitt
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany; (E.F.); (C.L.); (M.S.); (J.P.)
| | - Dana Cialla-May
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany; (E.F.); (C.L.); (M.S.); (J.P.)
- Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany
| | - Juergen Popp
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany; (E.F.); (C.L.); (M.S.); (J.P.)
- Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany
| |
Collapse
|
7
|
Borșa RM, Toma V, Onaciu A, Moldovan CS, Mărginean R, Cenariu D, Știufiuc GF, Dinu CM, Bran S, Opriș HO, Văcăraș S, Onișor-Gligor F, Sentea D, Băciuț MF, Iuga CA, Știufiuc RI. Developing New Diagnostic Tools Based on SERS Analysis of Filtered Salivary Samples for Oral Cancer Detection. Int J Mol Sci 2023; 24:12125. [PMID: 37569501 PMCID: PMC10418512 DOI: 10.3390/ijms241512125] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 07/25/2023] [Accepted: 07/26/2023] [Indexed: 08/13/2023] Open
Abstract
Cancer still represents one of the biggest challenges in current medical practice. Among different types of cancer, oral cancer has a huge impact on patients due to its great visibility, which is more likely to create social stigma and increased anxiety. New early diagnose methods are still needed to improve treatment efficiency and patients' life quality. Raman/SERS (Surface Enhanced Raman Spectroscopy) spectroscopy has a unique and powerful potential for detecting specific molecules that can become priceless biomarkers in different pathologies, such as oral cancer. In this study, a batch of saliva samples obtained from a group of 17 patients with oro-maxillofacial pathologies compared with saliva samples from 18 healthy donors using the aforementioned methods were evaluated. At the same time, opiorphin, potassium thiocyanate and uric acid were evaluated as potential specific biomarkers for oro-maxillofacial pathologies using multivariate analysis. A careful examination of SERS spectra collected on saliva samples showed that the spectra are dominated by the vibrational bands of opiorphin, potassium thiocyanate and uric acid. Given the fact that all these small molecules are found in very small amounts, we filtrated all the samples to get rid of large molecules and to improve our analysis. By using solid plasmonic substrates, we were able to gain information about molecular concentration and geometry of interaction. On the other hand, the multivariate analysis of the salivary spectra contributed to developing a new detection method for oral cancer.
Collapse
Affiliation(s)
- Rareș-Mario Borșa
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | - Valentin Toma
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | - Anca Onaciu
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | - Cristian-Silviu Moldovan
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | - Radu Mărginean
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | - Diana Cenariu
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
| | | | - Cristian-Mihail Dinu
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Simion Bran
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Horia-Octavian Opriș
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Sergiu Văcăraș
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Florin Onișor-Gligor
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Dorin Sentea
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Mihaela-Felicia Băciuț
- Dental Medicine Faculty, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania; (R.-M.B.); (C.-M.D.); (S.B.); (H.-O.O.); (S.V.); (F.O.-G.); (M.-F.B.)
- Department of Maxillofacial Surgery and Implantology, “Iuliu Hațieganu” University of Medicine and Pharmacy, Iuliu Hossu 37, 400029 Cluj-Napoca, Romania
- County Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania;
| | - Cristina-Adela Iuga
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
- Department of Pharmaceutical Analysis, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy, Pasteur 6, 400349 Cluj-Napoca, Romania
| | - Rareș-Ionuț Știufiuc
- Research Center for Advanced Medicine—MedFuture, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania; (V.T.); (A.O.); (C.-S.M.); (R.M.); (D.C.); (C.-A.I.)
- Department of Pharmaceutical Physics-Biophysics, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, Pasteur 6, 400349 Cluj-Napoca, Romania
- TRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania
| |
Collapse
|
8
|
Yi K, Fan Z, Ran Q, Jia K, Liu X, Wang L. Scalable fabrication of silver covered polyurethane nanofibers as flexible SERS nanosensors for aflatoxin detection. Talanta 2023; 263:124636. [PMID: 37247450 DOI: 10.1016/j.talanta.2023.124636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 04/07/2023] [Accepted: 05/02/2023] [Indexed: 05/31/2023]
Abstract
Flexible surface enhanced Raman spectroscopy (SERS) nanosensors, constructed by integration of plasmonic nanostructures with polymeric substrates, have received increasing research interests for recent decades. When compared to abundant works on optimization of the plasmonic nanostructures, the research involving the influence of polymeric substrates on analytical performance of resultant flexible SESR nanosensors is unexpectedly limited. Herein, the ultra-thin silver layer has been deposited on the electrospun polyurethane (ePU) nanofibrous membranes via vacuum evaporation to prepare the flexible SRES nanosensors. Interestingly, we find that the molecular weight and polydispersion index of synthesized PU play important roles in regulating the fine morphology of electrospun nanofibers, which in turns determine the Raman enhancement of resultant flexible SERS nanosensors. Specifically, the optimized SERS nanosensor, obtained by evaporating 10 nm silver layer on top of nanofibers derived from electrospinning of PU with a weight-average molecular weight of 140,354 and polydispersion index of 1.26, enables label-free detection of the carcinogen of aflatoxin down to 0.1 nM. Thanks to its scalable fabrication and good sensitivity, the current work opens new way for design of cost-effective flexible SERS nanosensors for environmental monitoring and food security applications.
Collapse
Affiliation(s)
- Keyu Yi
- School of Materials and Energy, University of Electronic Science and Technology of China, 610054, Chengdu, China
| | - Zilin Fan
- School of Materials and Energy, University of Electronic Science and Technology of China, 610054, Chengdu, China
| | - Qimeng Ran
- School of Materials and Energy, University of Electronic Science and Technology of China, 610054, Chengdu, China
| | - Kun Jia
- School of Materials and Energy, University of Electronic Science and Technology of China, 610054, Chengdu, China; Sichuan Province Engineering Technology Research Center of Novel CN Polymeric Materials, Chengdu, China.
| | - Xiaobo Liu
- School of Materials and Energy, University of Electronic Science and Technology of China, 610054, Chengdu, China; Sichuan Province Engineering Technology Research Center of Novel CN Polymeric Materials, Chengdu, China
| | - Lei Wang
- Department of Medical Ultrasound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 610072, Chengdu, China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, 610072, Chengdu, China.
| |
Collapse
|
9
|
Deng X, Wang S, Zhou W, Xu M, Chen B, Zhang W. Wrinkle-bioinspired silver nanowire surface enhanced Raman scattering sensors for pesticide molecule detection. Anal Bioanal Chem 2023:10.1007/s00216-023-04702-x. [PMID: 37071141 DOI: 10.1007/s00216-023-04702-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 04/09/2023] [Accepted: 04/12/2023] [Indexed: 04/19/2023]
Abstract
We demonstrate wrinkle-bioinspired flexible SERS sensor covered by silver nanowire (AgNWs) network for the detection of pesticide molecules. Compared with the silver film deposition substrates, the wrinkle-bioinspired AgNWs SERS substrates show stronger SERS effect, which were attributed to the electromagnetic field enhancement posed by the relatively high density "hot spots" of AgNWs. In order to investigate the adsorption performance of wrinkle-bioinspired flexible sensors, we measured the corresponding contact angles of AgNWs on the substrate surfaces before and after plasma treatment and found that the AgNWs treated with plasma are more hydrophilic than that without plasma treatment. Additionally, the wrinkle-bioinspired SERS sensors show different SERS activities under different tensile strain, and the 10-6 mol/L concentration of Rhodamine dye (R6G) molecules can be detected by portable Raman spectra, reducing greatly detection cost. The surface plasmon resonance of AgNWs is induced by adjusting the deformation of AgNWs substrate, enhancing the SERS signal. This reliability of wrinkle-bioinspired SERS sensors is further verified by in situ detection of pesticide molecules.
Collapse
Affiliation(s)
- Xue Deng
- College of Engineering, China Agricultural University, Beijing, 100083, China
| | - Song Wang
- College of Engineering, China Agricultural University, Beijing, 100083, China
| | - Wei Zhou
- College of Engineering, China Agricultural University, Beijing, 100083, China
| | - Minghao Xu
- College of Engineering, China Agricultural University, Beijing, 100083, China
| | - Bo Chen
- Aerospace Information Research Institute, Chinese Academy of Science, Beijing, 100190, China
- University of Chinese Academy of Sciences, Beijing, 100049, China
| | - Wenqiang Zhang
- College of Engineering, China Agricultural University, Beijing, 100083, China.
| |
Collapse
|
10
|
Linh VTN, Lee MY, Mun J, Kim Y, Kim H, Han IW, Park SG, Choi S, Kim DH, Rho J, Jung HS. 3D plasmonic coral nanoarchitecture paper for label-free human urine sensing and deep learning-assisted cancer screening. Biosens Bioelectron 2023; 224:115076. [PMID: 36641876 DOI: 10.1016/j.bios.2023.115076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 12/13/2022] [Accepted: 01/07/2023] [Indexed: 01/11/2023]
Abstract
Practical human biofluid sensing requires a sensor device to differentiate patients from the normal group with high sensitivity and specificity. Label-free molecular identification from human biofluids allows direct classification of abnormal samples, providing insights for disease diagnosis and finding of new biomarkers. Here, we introduce a label-free surface-enhanced Raman scattering sensor based on a three-dimensional plasmonic coral nanoarchitecture (3D-PCN), which has strong electromagnetic field enhancement through multiple hot spots. The 3D-PCN was synthesized on a paper substrate via direct one-step gold reduction, forming a coral-like nanoarchitecture with high absorption property for biofluids. This was fabricated as a urine test strip and then integrated with a handheld Raman system to develop an on-site urine diagnostic platform. The developed platform successfully classified the human prostate and pancreatic cancer urines in a label-free method supported by two types of deep learning networks, with high clinical sensitivity and specificity. Our technology has the potential to be utilized not only for urinary cancer diagnosis but also for various human biofluid sensing systems as a future point-of-care testing platform.
Collapse
Affiliation(s)
- Vo Thi Nhat Linh
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, South Korea
| | - Min-Young Lee
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, South Korea; Biomedical Engineering Research Center, Samsung Medical Center, Seoul, 06351, South Korea
| | - Jungho Mun
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - Yeseul Kim
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - Hongyoon Kim
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea
| | - In Woong Han
- Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea
| | - Sung-Gyu Park
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, South Korea
| | - Samjin Choi
- Department of Biomedical Engineering, College of Medicine, Kyung Hee University, Seoul, 02447, South Korea.
| | - Dong-Ho Kim
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, South Korea.
| | - Junsuk Rho
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea; POSCO-POSTECH-RIST Convergence Research Center for Flat Optics and Metaphotonics, Pohang, 37673, South Korea.
| | - Ho Sang Jung
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, 51508, South Korea.
| |
Collapse
|
11
|
Krishnan S, Kanthaje S, Punchappady DR, Mujeeburahiman M, Ratnacaram CK. Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis. J Cancer Res Clin Oncol 2023; 149:951-967. [PMID: 35764700 DOI: 10.1007/s00432-022-04113-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Accepted: 06/06/2022] [Indexed: 11/25/2022]
Abstract
PURPOSE Prostate cancer (PCa) is the second most commonly diagnosed cancer in men in Western and Asian countries. Serum prostate-specific antigen (PSA) test has been the routine diagnostic method despite the tremendous research in diagnostic markers for early detection of PCa. A shift towards a promising and potential biomarker for PCa detection is through metabolomic profiling of biofluids, particularly the blood and urine samples. Finding reliable, routinely usable circulating metabolite biomarkers may not be a distant reality. METHODS We performed a PubMed-based literature search of metabolite biomarkers in blood and urine for the early detection of prostate cancer. The timeline of these searches was limited between 2007 and 2022 and the following keywords were used: 'metabolomics', 'liquid biopsy', 'circulating metabolites', 'serum metabolite', 'plasma metabolite', and 'urine metabolite' with respect to 'prostate cancer'. We focussed only on diagnosis-based studies with only the subject-relevant articles published in the English language and excluded all of the other irrelevant publications that included prostate tissue biomarkers and cell line biomarkers. RESULTS We have consolidated all the blood and urine-based potential metabolite candidates in individual as well as panels, including lipid classes, fatty acids, amino acids, and volatile organic compounds which may become useful for PCa diagnosis. CONCLUSION All these metabolome findings unveil the impact of different dimensions of PCa development, giving a promising strategy to diagnose the disease since suspected individuals can be subjected to repeated and largescale blood and urine testing.
Collapse
Affiliation(s)
- Sabareeswaran Krishnan
- Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India
- Department of Urology, Yenepoya Medical College Hospital, Deralakatte, Mangaluru, 575018, Karnataka, India
| | - Shruthi Kanthaje
- Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India
| | - Devasya Rekha Punchappady
- Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India
| | - M Mujeeburahiman
- Department of Urology, Yenepoya Medical College Hospital, Deralakatte, Mangaluru, 575018, Karnataka, India.
| | - Chandrahas Koumar Ratnacaram
- Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India.
| |
Collapse
|
12
|
Kim JH, An YJ, Kim TM, Kim JE, Park S, Choi SH. Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics. Cancer Med 2023; 12:4679-4689. [PMID: 35941814 PMCID: PMC9972060 DOI: 10.1002/cam4.5083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 07/01/2022] [Accepted: 07/07/2022] [Indexed: 11/05/2022] Open
Abstract
PURPOSE Primary central nervous system lymphoma (PCNSL) is an uncommon extranodal non-Hodgkin's lymphoma. Here, the feasibility of nuclear magnetic resonance (NMR) metabolomics for the diagnosis and prognosis prediction of PCNSL, as well as its correlation with magnetic resonance imaging (MRI) characteristics, was assessed. PATIENTS AND METHODS Cerebrospinal fluid (CSF) samples from PCNSL and normal groups (n = 41 for each) were obtained along with MRI data including pre- and postcontrast as well as T1-, T2-, and diffusion-weighted imaging for the treatment-naïve PCNSL patients (n = 24). The CSF samples were analyzed using nuclear magnetic resonance (NMR). RESULTS The CSF NMR metabolomic exhibited clear differences with a diagnostic sensitivity of 100% and a specificity of 97.6%. The citrate level of the leptomeningeal enhancement (LE) (+) group was significantly lower than that of the LE (-) group (p = 0.018). In addition, the MRI apparent diffusion coefficient (ADC) value of the tumor was positively correlated with the glucose level (p = 0.025). However, none of the marker metabolites were significant prognosis predictors in univariate analysis. CONCLUSIONS In conclusion, the NMR metabolomics could be helpful to diagnose PCNSL, but not for the prognosis, and MRI features (LE or ADC) can reflect the metabolic profiles of PCNSL.
Collapse
Affiliation(s)
- Jae Hyun Kim
- Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Yong Jin An
- College of Pharmacy, Natural Product Research Institute, Seoul National University, Seoul, Republic of Korea
| | - Tae Min Kim
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Jeong Eun Kim
- Department of Neurosurgery, Seoul National University Hospital, Seoul, Republic of Korea
| | - Sunghyouk Park
- College of Pharmacy, Natural Product Research Institute, Seoul National University, Seoul, Republic of Korea
| | - Seung Hong Choi
- Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Republic of Korea.,Center for Nanoparticle Research, Institute for Basic Science, and School of Chemical and Biological Engineering, Seoul National University, Seoul, Republic of Korea
| |
Collapse
|
13
|
Constantinou M, Hadjigeorgiou K, Abalde-Cela S, Andreou C. Label-Free Sensing with Metal Nanostructure-Based Surface-Enhanced Raman Spectroscopy for Cancer Diagnosis. ACS Appl Nano Mater 2022; 5:12276-12299. [PMID: 36210923 PMCID: PMC9534173 DOI: 10.1021/acsanm.2c02392] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 07/27/2022] [Indexed: 05/03/2023]
Abstract
Surface-Enhanced Raman Spectroscopy (SERS) is a powerful analytical technique for the detection of small analytes with great potential for medical diagnostic applications. Its high sensitivity and excellent molecular specificity, which stems from the unique fingerprint of molecular species, have been applied toward the detection of different types of cancer. The noninvasive and rapid detection offered by SERS highlights its applicability for point-of-care (PoC) deployment for cancer diagnosis, screening, and staging, as well as for predicting tumor recurrence and treatment monitoring. This review provides an overview of the progress in label-free (direct) SERS-based chemical detection for cancer diagnosis with the main focus on the advances in the design and preparation of SERS substrates on the basis of metal nanoparticle structures formed via bottom-up strategies. It begins by introducing a synopsis of the working principles of SERS, including key chemometric approaches for spectroscopic data analysis. Then it introduces the advances of label-free sensing with SERS in cancer diagnosis using biofluids (blood, urine, saliva, sweat) and breath as the detection media. In the end, an outlook of the advances and challenges in cancer diagnosis via SERS is provided.
Collapse
Affiliation(s)
- Marios Constantinou
- Department
of Electrical and Computer Engineering, University of Cyprus, Nicosia, 2112, Cyprus
| | - Katerina Hadjigeorgiou
- Department
of Electrical and Computer Engineering, University of Cyprus, Nicosia, 2112, Cyprus
| | - Sara Abalde-Cela
- International
Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, Braga 4715-330, Portugal
| | - Chrysafis Andreou
- Department
of Electrical and Computer Engineering, University of Cyprus, Nicosia, 2112, Cyprus
| |
Collapse
|
14
|
Iancu SD, Cozan RG, Stefancu A, David M, Moisoiu T, Moroz-Dubenco C, Bajcsi A, Chira C, Andreica A, Leopold LF, Eniu D, Staicu A, Goidescu I, Socaciu C, Eniu DT, Diosan L, Leopold N. SERS liquid biopsy in breast cancer. What can we learn from SERS on serum and urine? Spectrochim Acta A Mol Biomol Spectrosc 2022; 273:120992. [PMID: 35220052 DOI: 10.1016/j.saa.2022.120992] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Revised: 01/21/2022] [Accepted: 02/01/2022] [Indexed: 06/14/2023]
Abstract
SERS analysis of biofluids, coupled with classification algorithms, has recently emerged as a candidate for point-of-care medical diagnosis. Nonetheless, despite the impressive results reported in the literature, there are still gaps in our knowledge of the biochemical information provided by the SERS analysis of biofluids. Therefore, by a critical assignment of the SERS bands, our work aims to provide a systematic analysis of the molecular information that can be achieved from the SERS analysis of serum and urine obtained from breast cancer patients and controls. Further, we compared the relative performance of five different machine learning algorithms for breast cancer and control samples classification based on the serum and urine SERS datasets, and found comparable classification accuracies in the range of 61-89%. This result is not surprising since both biofluids show striking similarities in their SERS spectra providing similar metabolic information, related to purine metabolites. Lastly, by carefully comparing the two datasets (i.e., serum and urine) we show that it is possible to link the misclassified samples to specific metabolic imbalances, such as carotenoid levels, or variations in the creatinine concentration.
Collapse
Affiliation(s)
- Stefania D Iancu
- Faculty of Physics, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Ramona G Cozan
- Faculty of Physics, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Andrei Stefancu
- Faculty of Physics, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Maria David
- Faculty of Chemistry and Chemical Engineering, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania
| | - Tudor Moisoiu
- Clinical Institute of Urology and Renal Transplant, 400006 Cluj-Napoca, Romania; Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania; Biomed Data Analytics SRL, 400696 Cluj-Napoca, Romania
| | - Cristiana Moroz-Dubenco
- Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Adel Bajcsi
- Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Camelia Chira
- Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania; Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Anca Andreica
- Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania
| | - Loredana F Leopold
- Faculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
| | - Daniela Eniu
- Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
| | - Adelina Staicu
- Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
| | - Iulian Goidescu
- Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
| | - Carmen Socaciu
- Faculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania; BIODIATECH Research Centre for Applied Biotechnology, SC Proplanta, 400478 Cluj-Napoca, Romania
| | - Dan T Eniu
- Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania; Department of Surgical and Gynecological Oncology, Ion Chiricuta Clinical Cancer Center, 400015 Cluj-Napoca, Romania
| | - Laura Diosan
- Department of Computer Science, Faculty of Mathematics and Computer Science, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania.
| | - Nicolae Leopold
- Faculty of Physics, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania; Biomed Data Analytics SRL, 400696 Cluj-Napoca, Romania.
| |
Collapse
|
15
|
Yang Z, Su HS, You EM, Liu S, Li Z, Zhang Y. High Uniformity and Enhancement Au@AgNS 3D Substrates for the Diagnosis of Breast Cancer. ACS Omega 2022; 7:15223-15230. [PMID: 35572747 PMCID: PMC9089677 DOI: 10.1021/acsomega.2c01453] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Accepted: 04/08/2022] [Indexed: 06/15/2023]
Abstract
Breast cancer appears to be one of the leading causes of cancer-related morbidity and mortality for women worldwide. The accurate and rapid diagnosis of breast cancer is hence critical for the treatment and prognosis of patients. With the vibrational fingerprint information and high detection sensitivity, surface-enhanced Raman spectroscopy (SERS) has been extensively applied in biomedicine. Here, an optimized bimetallic nanosphere (Au@Ag NS) 3D substrate was fabricated for the aim of the diagnosis of breast cancer based on the SERS analysis of the extracellular metabolites. The unique stacking mode of 3D Au@Ag NSs provided multiple plasmonic hot spots according to the theoretical calculations of the electromagnetic field distribution. The low relative standard deviation (RSD = 2.7%) and high enhancement factor (EF = 1.42 × 105) proved the uniformity and high sensitivity. More importantly, the normal breast cells and breast cancer cells could be readily distinguished from the corresponding SERS spectra based on the extracellular metabolites. Furthermore, the clear clusters of SERS spectra from MCF-7 and MDA-MB-231 extracellular metabolites in the orthogonal partial least-squares discriminant analysis plot indicate the distinct metabolic fingerprint between breast cancer cells, which imply their potential clinical application in the diagnosis of breast cancer.
Collapse
Affiliation(s)
- Zhengxia Yang
- CAS
Key Laboratory of Design and Assembly of Functional Nanostructures,
and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute
of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen
Institute of Rare Earth Materials, Haixi Institute, Xiamen Key Laboratory
of Rare Earth Photoelectric Functional Materials, Chinese Academy of Sciences, Xiamen 361021, P. R. China
| | - Hai-Sheng Su
- CAS
Key Laboratory of Design and Assembly of Functional Nanostructures,
and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute
of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen
Institute of Rare Earth Materials, Haixi Institute, Xiamen Key Laboratory
of Rare Earth Photoelectric Functional Materials, Chinese Academy of Sciences, Xiamen 361021, P. R. China
| | - En-Ming You
- State
Key Laboratory of Physical Chemistry of Solid Surfaces, College of
Chemistry and Chemical Engineering, Xiamen
University, Xiamen 361005, China
| | - Siying Liu
- CAS
Key Laboratory of Design and Assembly of Functional Nanostructures,
and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute
of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen
Institute of Rare Earth Materials, Haixi Institute, Xiamen Key Laboratory
of Rare Earth Photoelectric Functional Materials, Chinese Academy of Sciences, Xiamen 361021, P. R. China
- University
of Chinese Academy of Sciences, Beijing 100049, P. R.
China
| | - Zihang Li
- Wenzhou-Kean
University, 88 Daxue
Road, Ouhai, Wenzhou, Zhejiang
Province 325060, China
| | - Yun Zhang
- CAS
Key Laboratory of Design and Assembly of Functional Nanostructures,
and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute
of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen
Institute of Rare Earth Materials, Haixi Institute, Xiamen Key Laboratory
of Rare Earth Photoelectric Functional Materials, Chinese Academy of Sciences, Xiamen 361021, P. R. China
- University
of Chinese Academy of Sciences, Beijing 100049, P. R.
China
- Ganjiang
Innovation Academy, Chinese Academy of Sciences, Ganzhou, Jiangxi 341000, P. R. China
| |
Collapse
|
16
|
Moisoiu T, Dragomir MP, Iancu SD, Schallenberg S, Birolo G, Ferrero G, Burghelea D, Stefancu A, Cozan RG, Licarete E, Allione A, Matullo G, Iacob G, Bálint Z, Badea RI, Naccarati A, Horst D, Pardini B, Leopold N, Elec F. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer. Mol Med 2022; 28:39. [PMID: 35365098 PMCID: PMC8973824 DOI: 10.1186/s10020-022-00462-z] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2021] [Accepted: 03/07/2022] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Bladder cancer (BC) has the highest per-patient cost of all cancer types. Hence, we aim to develop a non-invasive, point-of-care tool for the diagnostic and molecular stratification of patients with BC based on combined microRNAs (miRNAs) and surface-enhanced Raman spectroscopy (SERS) profiling of urine. METHODS Next-generation sequencing of the whole miRNome and SERS profiling were performed on urine samples collected from 15 patients with BC and 16 control subjects (CTRLs). A retrospective cohort (BC = 66 and CTRL = 50) and RT-qPCR were used to confirm the selected differently expressed miRNAs. Diagnostic accuracy was assessed using machine learning algorithms (logistic regression, naïve Bayes, and random forest), which were trained to discriminate between BC and CTRL, using as input either miRNAs, SERS, or both. The molecular stratification of BC based on miRNA and SERS profiling was performed to discriminate between high-grade and low-grade tumors and between luminal and basal types. RESULTS Combining SERS data with three differentially expressed miRNAs (miR-34a-5p, miR-205-3p, miR-210-3p) yielded an Area Under the Curve (AUC) of 0.92 ± 0.06 in discriminating between BC and CTRL, an accuracy which was superior either to miRNAs (AUC = 0.84 ± 0.03) or SERS data (AUC = 0.84 ± 0.05) individually. When evaluating the classification accuracy for luminal and basal BC, the combination of miRNAs and SERS profiling averaged an AUC of 0.95 ± 0.03 across the three machine learning algorithms, again better than miRNA (AUC = 0.89 ± 0.04) or SERS (AUC = 0.92 ± 0.05) individually, although SERS alone performed better in terms of classification accuracy. CONCLUSION miRNA profiling synergizes with SERS profiling for point-of-care diagnostic and molecular stratification of BC. By combining the two liquid biopsy methods, a clinically relevant tool that can aid BC patients is envisaged.
Collapse
Affiliation(s)
- Tudor Moisoiu
- Clinical Institute of Urology and Renal Transplantation, 400006, Cluj-Napoca, Romania.,Iuliu Hatieganu University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania.,Biomed Data Analytics SRL, 400696, Cluj-Napoca, Romania
| | - Mihnea P Dragomir
- Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, 10117, Berlin, Germany. .,German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
| | - Stefania D Iancu
- Faculty of Physics, Babeș-Bolyai University, 400084, Cluj-Napoca, Romania
| | - Simon Schallenberg
- Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, 10117, Berlin, Germany
| | - Giovanni Birolo
- Department of Medical Sciences, University of Turin, 10126, Turin, Italy
| | - Giulio Ferrero
- Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole, 10, 10043, Orbassano, Italy
| | - Dan Burghelea
- Clinical Institute of Urology and Renal Transplantation, 400006, Cluj-Napoca, Romania.,Iuliu Hatieganu University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
| | - Andrei Stefancu
- Faculty of Physics, Babeș-Bolyai University, 400084, Cluj-Napoca, Romania
| | - Ramona G Cozan
- Faculty of Physics, Babeș-Bolyai University, 400084, Cluj-Napoca, Romania
| | - Emilia Licarete
- Faculty of Biology, Babeș-Bolyai University, 400015, Cluj-Napoca, Romania
| | - Alessandra Allione
- Department of Medical Sciences, University of Turin, 10126, Turin, Italy
| | - Giuseppe Matullo
- Department of Medical Sciences, University of Turin, 10126, Turin, Italy
| | - Gheorghita Iacob
- Clinical Institute of Urology and Renal Transplantation, 400006, Cluj-Napoca, Romania
| | - Zoltán Bálint
- Faculty of Physics, Babeș-Bolyai University, 400084, Cluj-Napoca, Romania
| | - Radu I Badea
- Iuliu Hatieganu University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania.,Octavian Fodor Regional Institute of Gastroenterology and Hepatology, 400162, Cluj-Napoca, Romania
| | - Alessio Naccarati
- Candiolo Cancer Institute-FPO IRCCS, 10060, Candiolo, Turin, Italy.,Italian Institute for Genomic Medicine (IIGM), IRCCS Candiolo, 10060, Candiolo, Turin, Italy
| | - David Horst
- Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, 10117, Berlin, Germany.,German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Barbara Pardini
- Candiolo Cancer Institute-FPO IRCCS, 10060, Candiolo, Turin, Italy. .,Italian Institute for Genomic Medicine (IIGM), IRCCS Candiolo, 10060, Candiolo, Turin, Italy.
| | - Nicolae Leopold
- Biomed Data Analytics SRL, 400696, Cluj-Napoca, Romania. .,Faculty of Physics, Babeș-Bolyai University, 400084, Cluj-Napoca, Romania.
| | - Florin Elec
- Clinical Institute of Urology and Renal Transplantation, 400006, Cluj-Napoca, Romania. .,Iuliu Hatieganu University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania.
| |
Collapse
|
17
|
Gaba F, Tipping WJ, Salji M, Faulds K, Graham D, Leung HY. Raman Spectroscopy in Prostate Cancer: Techniques, Applications and Advancements. Cancers (Basel) 2022; 14:cancers14061535. [PMID: 35326686 PMCID: PMC8946151 DOI: 10.3390/cancers14061535] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Revised: 03/09/2022] [Accepted: 03/14/2022] [Indexed: 02/04/2023] Open
Abstract
Optical techniques are widely used tools in the visualisation of biological species within complex matrices, including biopsies, tissue resections and biofluids. Raman spectroscopy is an emerging analytical approach that probes the molecular signature of endogenous cellular biomolecules under biocompatible conditions with high spatial resolution. Applications of Raman spectroscopy in prostate cancer include biopsy analysis, assessment of surgical margins and monitoring of treatment efficacy. The advent of advanced Raman imaging techniques, such as stimulated Raman scattering, is creating opportunities for real-time in situ evaluation of prostate cancer. This review provides a focus on the recent preclinical and clinical achievements in implementing Raman-based techniques, highlighting remaining challenges for clinical applications. The research and clinical results achieved through in vivo and ex vivo Raman spectroscopy illustrate areas where these evolving technologies can be best translated into clinical practice.
Collapse
Affiliation(s)
- Fortis Gaba
- Department of Urology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; (F.G.); (M.S.)
- School of Medicine, University of Glasgow, Glasgow G12 8QQ, UK
| | - William J. Tipping
- Department for Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1RD, UK; (W.J.T.); (K.F.); (D.G.)
| | - Mark Salji
- Department of Urology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; (F.G.); (M.S.)
- Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK
- CRUK Beatson Institute, Bearsden, Glasgow G61 1BD, UK
| | - Karen Faulds
- Department for Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1RD, UK; (W.J.T.); (K.F.); (D.G.)
| | - Duncan Graham
- Department for Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1RD, UK; (W.J.T.); (K.F.); (D.G.)
| | - Hing Y. Leung
- Department of Urology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; (F.G.); (M.S.)
- Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK
- CRUK Beatson Institute, Bearsden, Glasgow G61 1BD, UK
- Correspondence:
| |
Collapse
|
18
|
Chan KM, Gleadle JM, O'Callaghan M, Vasilev K, MacGregor M. Prostate cancer detection: a systematic review of urinary biosensors. Prostate Cancer Prostatic Dis 2022; 25:39-46. [PMID: 34997229 DOI: 10.1038/s41391-021-00480-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Revised: 11/19/2021] [Accepted: 11/25/2021] [Indexed: 02/04/2023]
Abstract
BACKGROUND Current diagnostic methods for prostate cancer are invasive and lack specificity towards aggressive forms of the disease, which can lead to overtreatment. A new class of non-invasive alternatives is under development, in which urinary biomarkers are detected using biosensing devices to offer rapid and accurate prostate cancer diagnosis. These different approaches are systematically reviewed and their potential for translation to clinical practice is evaluated. METHODS A systematic review of the literature was performed in May 2021 using PubMed Medline database, Embase, and Web of Science. The objective was to review the structural designs and performance of biosensors tested on urine samples from patients with prostate cancer. RESULTS A total of 76 records were identified. After screening and eligibility, 14 articles were included and are discussed in this paper. The biosensors were discussed based on the target biomarkers and detection technologies used, as well as the results of the clinical studies. Most of the works reported good discrimination between patients with prostate cancer and controls. CONCLUSIONS This review highlights the potential of urinary biosensors for non-invasive prostate cancer detection. However, clinical studies have so far only been conducted on small cohorts of patient, with large scale trials still needed to validate the proposed approaches. Overall, the consensus arising from the proof of concepts studies reviewed here, is that an adequate combination of biomarkers into multiplex biosensor platforms is required to achieve accurate diagnostic tests. Furthermore, whether such devices can discriminate between aggressive and indolent cancer has not yet been addressed, because it entails optimized biomarkers panels and long-term clinical trials.
Collapse
Affiliation(s)
- Kit Man Chan
- UniSA STEM, University of South Australia, Adelaide, SA, 5095, Australia
| | - Jonathan M Gleadle
- Department of Renal Medicine, Flinders Medical Centre, Flinders University, Bedford Park, SA, 5042, Australia.,Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia
| | - Michael O'Callaghan
- Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.,Urology Unit, Flinders Medical Centre, Flinders University, Bedford Park, SA, 5042, Australia
| | - Krasimir Vasilev
- Future Industries Institute, UniSA STEM, University of South Australia, Adelaide, SA, 5095, Australia
| | - Melanie MacGregor
- Future Industries Institute, UniSA STEM, University of South Australia, Adelaide, SA, 5095, Australia.
| |
Collapse
|
19
|
Plou J, Valera PS, García I, de Albuquerque CDL, Carracedo A, Liz-Marzán LM. Prospects of Surface-Enhanced Raman Spectroscopy for Biomarker Monitoring toward Precision Medicine. ACS Photonics 2022; 9:333-350. [PMID: 35211644 PMCID: PMC8855429 DOI: 10.1021/acsphotonics.1c01934] [Citation(s) in RCA: 29] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/21/2022] [Accepted: 01/24/2022] [Indexed: 05/14/2023]
Abstract
Future precision medicine will be undoubtedly sustained by the detection of validated biomarkers that enable a precise classification of patients based on their predicted disease risk, prognosis, and response to a specific treatment. Up to now, genomics, transcriptomics, and immunohistochemistry have been the main clinically amenable tools at hand for identifying key diagnostic, prognostic, and predictive biomarkers. However, other molecular strategies, including metabolomics, are still in their infancy and require the development of new biomarker detection technologies, toward routine implementation into clinical diagnosis. In this context, surface-enhanced Raman scattering (SERS) spectroscopy has been recognized as a promising technology for clinical monitoring thanks to its high sensitivity and label-free operation, which should help accelerate the discovery of biomarkers and their corresponding screening in a simpler, faster, and less-expensive manner. Many studies have demonstrated the excellent performance of SERS in biomedical applications. However, such studies have also revealed several variables that should be considered for accurate SERS monitoring, in particular, when the signal is collected from biological sources (tissues, cells or biofluids). This Perspective is aimed at piecing together the puzzle of SERS in biomarker monitoring, with a view on future challenges and implications. We address the most relevant requirements of plasmonic substrates for biomedical applications, as well as the implementation of tools from artificial intelligence or biotechnology to guide the development of highly versatile sensors.
Collapse
Affiliation(s)
- Javier Plou
- CIC
biomaGUNE, Basque Research
and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain
- Biomedical
Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine
(CIBER-BBN), 20014 Donostia-San Sebastián, Spain
- CIC
bioGUNE, Basque Research and Technology
Alliance (BRTA), 48160 Derio, Spain
| | - Pablo S. Valera
- CIC
biomaGUNE, Basque Research
and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain
- CIC
bioGUNE, Basque Research and Technology
Alliance (BRTA), 48160 Derio, Spain
| | - Isabel García
- CIC
biomaGUNE, Basque Research
and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain
- Biomedical
Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine
(CIBER-BBN), 20014 Donostia-San Sebastián, Spain
| | | | - Arkaitz Carracedo
- CIC
bioGUNE, Basque Research and Technology
Alliance (BRTA), 48160 Derio, Spain
- Biomedical
Research Networking Center in Cancer (CIBERONC), 48160, Derio, Spain
- Ikerbasque,
Basque Foundation for Science, 48009 Bilbao, Spain
- Translational
Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, 48160 Derio, Spain
| | - Luis M. Liz-Marzán
- CIC
biomaGUNE, Basque Research
and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain
- Biomedical
Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine
(CIBER-BBN), 20014 Donostia-San Sebastián, Spain
- Ikerbasque,
Basque Foundation for Science, 48009 Bilbao, Spain
- E-mail:
| |
Collapse
|
20
|
Moisoiu T, Iancu SD, Burghelea D, Dragomir MP, Iacob G, Stefancu A, Cozan RG, Antal O, Bálint Z, Muntean V, Badea RI, Licarete E, Leopold N, Elec FI. SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer. Biomedicines 2022; 10:233. [PMID: 35203443 PMCID: PMC8869590 DOI: 10.3390/biomedicines10020233] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 01/13/2022] [Accepted: 01/17/2022] [Indexed: 12/20/2022] Open
Abstract
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence worldwide, opening the discussion about the need for screening. However, no established screening tool currently exists for RC. To tackle this issue, we assessed surface-enhanced Raman scattering (SERS) profiling of serum as a liquid biopsy strategy to detect renal cell carcinoma (RCC), the most prevalent histologic subtype of RC. Thus, serum samples were collected from 23 patients with RCC and 27 controls (CTRL) presenting with a benign urological pathology such as lithiasis or benign prostatic hypertrophy. SERS profiling of deproteinized serum yielded SERS band spectra attributed mainly to purine metabolites, which exhibited higher intensities in the RCC group, and Raman bands of carotenoids, which exhibited lower intensities in the RCC group. Principal component analysis (PCA) of the SERS spectra showed a tendency for the unsupervised clustering of the two groups. Next, three machine learning algorithms (random forest, kNN, naïve Bayes) were implemented as supervised classification algorithms for achieving discrimination between the RCC and CTRL groups, yielding an AUC of 0.78 for random forest, 0.78 for kNN, and 0.76 for naïve Bayes (average AUC 0.77 ± 0.01). The present study highlights the potential of SERS liquid biopsy as a diagnostic and screening strategy for RCC. Further studies involving large cohorts and other urologic malignancies as controls are needed to validate the proposed SERS approach.
Collapse
|
21
|
Lu Y, Lin L, Ye J. Human metabolite detection by surface-enhanced Raman spectroscopy. Mater Today Bio 2022; 13:100205. [PMID: 35118368 PMCID: PMC8792281 DOI: 10.1016/j.mtbio.2022.100205] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 01/15/2022] [Accepted: 01/16/2022] [Indexed: 12/17/2022]
Abstract
Metabolites are important biomarkers in human body fluids, conveying direct information of cellular activities and physical conditions. Metabolite detection has long been a research hotspot in the field of biology and medicine. Surface-enhanced Raman spectroscopy (SERS), based on the molecular “fingerprint” of Raman spectrum and the enormous signal enhancement (down to a single-molecule level) by plasmonic nanomaterials, has proven to be a novel and powerful tool for metabolite detection. SERS provides favorable properties such as ultra-sensitive, label-free, rapid, specific, and non-destructive detection processes. In this review, we summarized the progress in recent 10 years on SERS-based sensing of endogenous metabolites at the cellular level, in tissues, and in biofluids, as well as drug metabolites in biofluids. We made detailed discussions on the challenges and optimization methods of SERS technique in metabolite detection. The combination of SERS with modern biomedical technology were also anticipated.
Collapse
Affiliation(s)
- Yao Lu
- State Key Laboratory of Oncogenes and Related Genes, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, PR China
| | - Li Lin
- State Key Laboratory of Oncogenes and Related Genes, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, PR China
- Corresponding author.
| | - Jian Ye
- State Key Laboratory of Oncogenes and Related Genes, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, PR China
- Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China
- Institute of Medical Robotics, Shanghai Jiao Tong University, Shanghai, 200240, PR China
- Corresponding author. State Key Laboratory of Oncogenes and Related Genes, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, PR China.
| |
Collapse
|
22
|
Xie T, Li P, Ge M, Chen S, Huang G, Li J, Gong M, Weng S, Yang L. Construction of Ag nanowire@Au nanoparticle nano nests with densely stacked small gaps for actively trapping molecules to realize diversity SERS detection. Analyst 2022; 147:2541-2548. [DOI: 10.1039/d2an00527a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The SERS detection method based nano nest model actively traps molecules by the capillary action to detect different kinds of molecules, such as pesticide residues, bioenergy substances, antibiotic residues and allergic reactions.
Collapse
Affiliation(s)
- Tao Xie
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Pan Li
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Department of Pharmacy, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei 230031, Anhui, China
| | - Meihong Ge
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Siyu Chen
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Guangyao Huang
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Junxiang Li
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Meiting Gong
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- University of Science & Technology of China, Hefei 230026, Anhui, China
| | - Shirui Weng
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Department of Pharmacy, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei 230031, Anhui, China
| | - Liangbao Yang
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Department of Pharmacy, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei 230031, Anhui, China
| |
Collapse
|
23
|
Gu Y, Xu D, Zou K, Zhou T, Zhu G, Yang G, Qu LL. Combined Paper Centrifugal Chromatographic Separation and SERS Detection for Multicomponent Substances. Anal Chem 2021; 93:8693-8697. [PMID: 34137589 DOI: 10.1021/acs.analchem.1c01625] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The separation and chemical analysis of mixtures in an emergency situation represent major challenges, especially in remote or poverty-stricken areas. A novel method was developed for the rapid separation and detection of multiple components via paper centrifugal chromatography, which costs as little as $2.26 US. The method was realized based on the combination of portable paper centrifugal chromatography and surface-enhanced Raman scattering (SERS) detection. This coupled technique was successfully implemented for the separation and qualitative analysis of a rhodamine 6G-crystal violet mixture and a colorless aniline-pyrocatechol-benzidine mixture. A chromatographic mobile phase was collected using absorbent cotton, which was demonstrated to have no effect on the SERS results. The optimized device achieved rapid and effective separation of the colorless aniline-pyrocatechol-benzidine mixture with a high centrifugal force (0.3303π2 N). The newly developed method involving multicomponent paper centrifugal chromatography-SERS detection will be of great value for emergency-related substance separation and analysis in remote and poor areas.
Collapse
Affiliation(s)
- Yingqiu Gu
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Di Xu
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Kun Zou
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Tingrong Zhou
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Gen Zhu
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Guohai Yang
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| | - Lu-Lu Qu
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China
| |
Collapse
|
24
|
Li T, Yu Z, Wang Z, Zhu Y, Zhang J. Optimized Tapered Fiber Decorated by Ag Nanoparticles for Raman Measurement with High Sensitivity. Sensors (Basel) 2021; 21:s21072300. [PMID: 33806065 PMCID: PMC8036424 DOI: 10.3390/s21072300] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/21/2021] [Revised: 03/15/2021] [Accepted: 03/23/2021] [Indexed: 11/18/2022]
Abstract
A tapered fiber decorated by Ag nanoparticles is prepared as a surface-enhanced Raman scattering (SERS) substrate. There are two key parameters during the preparation process, the fiber cone angle and the density of decorated AgNPs on the fiber tip surface. Their theoretical analysis on the forming mechanism and the optimization process is studied in detail. The tapered fibers with angles from 0.5 to 30° are successfully prepared, with a chemical method in a small tube using a bending interface. AgNPs with different densities are decorated on the surface of the tapered fibers with an electrostatic adsorption method. The optimized tapered fiber SERS probe with an angle of 12° and AgNPs density of 26.67% provides the detection of Rhodamine 6G (R6G) with 10−10 mol/L.
Collapse
Affiliation(s)
| | | | | | | | - Jie Zhang
- Correspondence: ; Tel.: +86-135-9413-5451
| |
Collapse
|
25
|
Geng X, Wu C, Liu S, Han Y, Song L, Zhang Y. Fabrication optimization and application of 3D hybrid SERS substrates. RSC Adv 2021; 11:31400-31407. [PMID: 35496872 PMCID: PMC9041343 DOI: 10.1039/d1ra04473g] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Accepted: 09/11/2021] [Indexed: 12/30/2022] Open
Abstract
Three-dimensional (3D) plasmonic nanostructures with nanoparticles that can be tuned have got a lot of attention in surface-enhanced Raman scattering (SERS) due to the unique 3D plasmonic coupling. Here, two nanoparticles, gold nanosphere (AuNS) and gold nanooctahedra (AuNO), were used to construct 3D hybrid SERS substrates to investigate the effect of nanoparticle spatial position on the SERS performance of the 3D nanostructure and to obtain 3D substrates with high SERS activity. And more hybrid combination possibilities were tested to explore the variation trend of hot spots generated when the nanoparticles were near. First, two-dimensional (2D) planar substrates were prepared using the air–liquid interface-assisted self-assembly method, to examine the effect of nanoparticle size on SERS performance. Then, 3D hybrid SERS substrates were further prepared layer by layer to discuss the effect of different combination methods within three layers on SERS performance. The optimized 3D hybrid substrate with the sandwich structure of AuNS/AuNO/AuNS performed the strongest SERS enhancement effect, whose intensity was 4.1 and 1.9 times that of AuNS/AuNS/AuNS and AuNO/AuNO/AuNO, respectively, and had good reproducibility (relative standard deviation (RSD) of 1.08%). Furthermore, the thiram molecular result showed that the prepared AuNS/AuNO/AuNS had good linear relationship (R2 of 0.991) and good molecule detection sensitivity (the minimum detection volume of thiram is 100 ppb), which demonstrated the great potential of the 3D hybrid SERS substrates in practical analysis. The SERS effect of 3D hybrid substrate composed of AuNS and AuNO can be adjusted by changing the size and location of nanoparticles in the substrate, and SERS effect of the optimized substrate was better than that prepared by single nanoparticles.![]()
Collapse
Affiliation(s)
- Xiaoyuan Geng
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
| | - Chen Wu
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
| | - Siying Liu
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
- University of Chinese Academy of Sciences, Beijing 100049, P. R. China
| | - Yu Han
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
| | - Liang Song
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
- Ganjiang Innovation Academy, Chinese Academy of Sciences, Jiangxi 341000, P. R. China
| | - Yun Zhang
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
- Xiamen Institute of Rare Earth Materials, Haixi Institute, Chinese Academy of Sciences, Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials, Xiamen 361021, P. R. China
- Ganjiang Innovation Academy, Chinese Academy of Sciences, Jiangxi 341000, P. R. China
- University of Chinese Academy of Sciences, Beijing 100049, P. R. China
| |
Collapse
|